ARTICLE | Product Development
A series of articles showcases innovation in tools and standards for generating evidence to support new therapies
By C. Simone Fishburn, Editor in Chief
November 4, 2023 12:52 AM UTC
All CEOs, all heads of R&D, all drug developers center their strategies around the central question: what is the level of evidence we need to get our therapy approved?
While the question has been around for as long as the industry, the answer is continually changing. …